SCHEMBL3753274

SCHEMBL3753274

O=Cc1ccc(-c2cccc(F)c2F)nc1Oc1cc(C(F)(F)F)ccc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 8/20 0.39
PDE10A Q9Y233 6/20 0.39
CHEK2 O96017 1/20 0.36
PDE6D O43924 1/20 0.35
PDE6A P16499 1/20 0.35
PDE6G P18545 1/20 0.35
PDE6B P35913 1/20 0.35
PDE6C P51160 1/20 0.35
PDE6H Q13956 1/20 0.35
GPBAR1 Q8TDU6 1/20 0.34
MPL P40238 1/20 0.34
TRPV3 Q8NET8 2/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
KCNH2 Q12809 1/20 0.34
KDR P35968 1/20 0.34
TEK Q02763 1/20 0.34
F7 P08709 1/20 0.33
F3 P13726 1/20 0.33
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3747206 0.91 ALK (0.38) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL3752299 0.87 ERN1 (0.36) PDE2APDE10APDCD1LG2CD274
SCHEMBL3757999 0.86 PPARG (0.35) PDE2APDE10APDCD1LG2CD274
SCHEMBL3751743 0.84 CD274 (0.37) PDE10AMAPTPDCD1LG2CD274
SCHEMBL3753385 0.83 HSD11B1 (0.41) MPLPDCD1LG2CD274
SCHEMBL3747340 0.82 KDM4E (0.44) GPBAR1KDRTEK
SCHEMBL3747192 0.81 MPL (0.40) PDE2APDE10AMPLPOLBPDCD1LG2
SCHEMBL3754331 0.79 ERN1 (0.42) PDCD1LG2CD274
SCHEMBL3753273 0.79 CTSA (0.37) PDE2APDE10APDCD1LG2CD274
SCHEMBL3752610 0.79 PDE2A (0.38) PDE2APDE10ACHEK2PDCD1LG2CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF NAPRT, PNPO, FABP3 PDE2A 1036/4885PDE10A 1701/4885CHEK2 3584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.